Olema Pharmaceuticals Inc... (OLMA)
NASDAQ: OLMA
· Real-Time Price · USD
5.52
0.26 (4.94%)
At close: Aug 15, 2025, 3:59 PM
5.54
0.36%
After-hours: Aug 15, 2025, 06:03 PM EDT
Olema Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 52.47M | 50.64M | 139.48M | 35.89M | 16.89M | 33.72M | 68.54M | 117.41M | 34.96M | 40.92M | 23.7M | 26.8M | 24.53M | 21.51M | 287.25M | 25.6M | 50.42M | 47.88M |
Short-Term Investments | 309.44M | 342.07M | 294.61M | 178.88M | 222.21M | 215.26M | 193.27M | 159.49M | 132.49M | 145.04M | 180.72M | 195.8M | 216.19M | 246.36M | 273.44M | 280.36M | 267.72M | 279.09M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 7.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 12.59M | 10.53M | 9.76M | 9.76M | 9.61M | 8.52M | n/a | 7.18M | 2.9M | 2.77M | 2.77M | 2.77M | 3.1M | 2.79M | 3.98M | 540K | 510K | 510K |
Receivables | n/a | 1.92M | 2.12M | 687K | 821K | 664K | 673K | 740K | 622K | 302K | 319K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | 2.27M | n/a | 4.09M | 3.21M | -302K | -319K | 1.92M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 5.81M | 276K | 366K | 188K | 171K | 177K | 1.68M | 2.74M | 2.06M | 1.05M | 1.5M | 1.63M | 996K | 491K | 462K | 432K | 463K | 759K |
Total Current Assets | 367.73M | 396.66M | 438.47M | 217.99M | 242.19M | 252.09M | 266.51M | 282.01M | 171.51M | 189.4M | 208.9M | 225.06M | 243.03M | 270.21M | 287.25M | 308.28M | 320.85M | 330.26M |
Property-Plant & Equipment | 1.69M | 1.71M | 2.06M | 2.42M | 2.76M | 3.09M | 3.26M | 3.61M | 3.21M | 3.6M | 3.98M | 4.17M | 4.48M | 4.41M | 4.72M | 975K | 866K | 526K |
Goodwill & Intangibles | n/a | 739K | 683K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 14.28M | 12.98M | 12.51M | 12.18M | 12.37M | 11.6M | 10.43M | 10.79M | 6.12M | 6.37M | 6.75M | 6.94M | 7.57M | 7.2M | 8.7M | 1.51M | 1.38M | 1.04M |
Total Assets | 382M | 409.64M | 450.98M | 230.17M | 254.56M | 263.69M | 276.94M | 292.8M | 177.62M | 195.77M | 215.65M | 232M | 250.6M | 277.42M | 295.94M | 309.8M | 322.23M | 331.3M |
Account Payables | 934K | 151K | 4.46M | 2.69M | 4.35M | 7.66M | 2.7M | 2.21M | 1.63M | 681K | 374K | 14K | 120K | 268K | 23K | 306K | 385K | 419K |
Deferred Revenue | n/a | n/a | n/a | n/a | 14.52M | -8.71M | n/a | n/a | 12.39M | n/a | n/a | n/a | 10.75M | n/a | 7.69M | n/a | n/a | n/a |
Short-Term Debt | 1.15M | n/a | n/a | n/a | 1.1M | n/a | 988K | 924K | 798K | 908K | n/a | 1.08M | 1.08M | 881K | n/a | n/a | n/a | n/a |
Other Current Liabilities | 32.01M | n/a | n/a | 3.79M | 17.02M | 91K | 11.24M | 8.59M | 1.15M | 12.98M | 68K | 6.98M | 1.33M | 6.43M | 260K | 323K | 2.05M | 1.2M |
Total Current Liabilities | 33.16M | 26.06M | 41.76M | 30.7M | 26.54M | 26.22M | 21.62M | 15.97M | 14.83M | 19.41M | 16.55M | 12.55M | 12.31M | 10.17M | 9.02M | 8.9M | 8.15M | 5.28M |
Long-Term Debt | 602K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 3.6M | 123K | 257K | 562K | 859K | 1.15M | 1.43M | 1.7M | 1.21M | 1.38M | 1.55M | 1.75M | 2.01M | 2.16M | 2.36M | n/a | n/a | n/a |
Total Liabilities | 36.77M | 26.19M | 42.02M | 31.26M | 27.39M | 27.38M | 23.05M | 17.66M | 16.04M | 20.79M | 18.1M | 14.3M | 14.32M | 12.33M | 11.38M | 8.9M | 8.15M | 5.28M |
Total Debt | 1.75M | 1.15M | 1.43M | 1.7M | 1.96M | 2.21M | 2.42M | 2.62M | 2.01M | 2.29M | 2.56M | 2.83M | 3.09M | 3.04M | 3.29M | n/a | n/a | n/a |
Common Stock | 7K | 7K | 6K | 4K | 4K | 4K | 4K | 4K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K |
Retained Earnings | -509.28M | -465.5M | -435.11M | -401.54M | -366.98M | -336.6M | -305.63M | -278.86M | -257.36M | -237.26M | -208.98M | -182.8M | -160.08M | -127.22M | -104.19M | -82.55M | -64.84M | -48.43M |
Comprehensive Income | 314K | 420K | 143K | 464K | -118K | -10K | 347K | -241K | -518K | -978K | -1.81M | -2.67M | -2.4M | -1.63M | -149K | 15K | -14K | -13K |
Shareholders Equity | 345.24M | 383.45M | 408.96M | 198.91M | 227.16M | 236.32M | 253.9M | 275.13M | 161.58M | 174.97M | 197.55M | 217.7M | 236.28M | 265.09M | 284.57M | 300.89M | 314.08M | 326.02M |
Total Investments | n/a | 342.07M | 294.61M | 178.88M | 222.21M | 215.26M | 200.44M | 159.49M | 132.49M | 145.04M | 180.72M | 195.8M | 216.19M | 246.36M | 273.44M | 280.36M | 267.72M | 279.09M |